Loading...
review article
Targeting LRG1 boosts immunotherapy
November 12, 2021
Vascular normalization therapy has the potential to facilitate drug delivery and lymphocyte infiltration in tumors. Yet, optimal targets and dosage regimens remain elusive. In this issue of Med, O’Connor et al. show that inhibition of LRG1 stabilizes the tumor-associated vasculature to enhance tumor response to both cytotoxic and immune therapies.
Type
review article
Authors
Publication date
2021-11-12
Published in
Volume
2
Issue
11
Start page
1195
End page
1197, e10
Peer reviewed
REVIEWED
EPFL units
Available on Infoscience
November 14, 2021
Use this identifier to reference this record